Table of Content

1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations

3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Rising Prevalence of Collagen Vascular Diseases
3.1.2. Cohesive Government Initiatives
3.1.3. Increasing Demand for Collagen-Based Cosmetic Products
3.1.4. Extensive Use of Collagen in Wound Healing Products
3.2. Restraints
3.2.1. High Cost of Treatment
3.2.2. Concerns Regarding Transfer of Diseases
3.3. Opportunities
3.3.1. Strong Pipeline of Drugs Such as RA (Rheumatoid Arthritis Drugs)
3.3.2. Growing Healthcare Expenditure in Major Emerging Economies
3.3.3. Growing R&D and Investment

4. MARKET SEGMENTATION
4.1. Global Collagen Vascular Diseases Market by Disease Type
4.1.1. Autoimmune Collagen Vascular Diseases
4.1.1.1. Lupus
4.1.1.2. Rheumatoid Arthritis
4.1.1.3. Scleroderma
4.1.2. Hereditary Collagen Vascular Diseases
4.2. Global Collagen Vascular Diseases Market by Diagnostics
4.2.1. Complete Blood Count
4.2.2. Erythrocyte Sedimentation Rate (ESR)
4.2.3. C-Reactive Protein
4.2.4. Rheumatoid Factor
4.2.5. Antinuclear Antibodies
4.2.6. Others (Urinalysis with Microscopic Analysis & Serum Creatinine)
4.3. Global Collagen Vascular Diseases Market by Therapeutics
4.3.1. Corticosteroids
4.3.2. Immunosuppressive Agents
4.3.3. Endothelin Receptor Antagonists
4.3.4. Others (Calcium Channel Blockers, PDE-5 Inhibitors & Chelating Agents)
4.4. Global Collagen Vascular Diseases Market by End-Users
4.4.1. Hospital & Clinics
4.4.2. Diagnostic Centers
4.4.3. Research Institutes

5. COMPETITIVE LANDSCAPE
5.1. Key Strategy Analysis
5.2. Key Company Analysis


6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World (RoW)

7. COMPANY PROFILES
7.1. AbbVie Inc.
7.2. Actelion Pharmaceuticals Ltd.
7.3. Advanced BioMatrix, Inc.
7.4. Amgen Inc.
7.5. Amryt Pharma PLC
7.6. Bayer AG
7.7. Beckman Coulter, Inc.
7.8. Bio-Rad Laboratories, Inc.
7.9. Bristol-Myers Squibb Co.
7.10. Cadila Healthcare Ltd.
7.11. Collagen Solutions PLC
7.12. ConnOils LLC
7.13. Corbus Pharmaceuticals Holdings, Inc.
7.14. Cytori Therapeutics Inc.
7.15. Eli Lilly and Co.
7.16. F. Hoffmann-La Roche AG
7.17. GELITA AG
7.18. GenWay Biotech, Inc.
7.19. Holista Colltech Ltd.
7.20. ImmuPharma PLC
7.21. Junc? Gelatines, S.L.
7.22. Merck KGaA
7.23. MorphoSys AG
7.24. Novartis International AG
7.25. Pfizer Inc
7.26. QIAGEN GmbH
7.27. Sanofi SA
7.28. Siemens Healthcare GmbH
7.29. Svar Life Science AB (Euro Diagnostica AB)
7.30. Thermo Fisher Scientific, Inc.



List of Figures


FIGURE # 1 GLOBAL COLLAGEN VASCULAR DISEASES MARKET BY DISEASE TYPE, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL COLLAGEN VASCULAR DISEASES MARKET BY THERAPEUTICS, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL COLLAGEN VASCULAR DISEASES MARKET BY END-USERS, 2017 VS 2023 (%)
FIGURE # 4 GLOBAL COLLAGEN VASCULAR DISEASES MARKET BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 5 US COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 UK COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 FRANCE COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 SPAIN COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 GERMANY COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ITALY COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 ROE COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 ROW COLLAGEN VASCULAR DISEASES MARKET SIZE, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL AUTOIMMUNE COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL HEREDITARY COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL COMPLETE BLOOD COUNT MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL ERYTHROCYTE SEDIMENTATION RATE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL C-REACTIVE PROTEIN MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL RHEUMATOID FACTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL ANTINUCLEAR ANTIBODIES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL IMMUNOSUPPRESSIVE AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL ENDOTHELIN RECEPTOR ANTAGONISTS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL HOSPITAL & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 20 GLOBAL COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 21 NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 22 NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2017-2023 ($ MILLION)
TABLE # 23 NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 24 NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 25 EUROPE COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 26 EUROPE COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2017-2023 ($ MILLION)
TABLE # 27 EUROPE COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 28 EUROPE COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 29 ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 30 ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2017-2023 ($ MILLION)
TABLE # 31 ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 32 ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 33 ROW COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2017-2023 ($ MILLION)
TABLE # 34 ROW COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2017-2023 ($ MILLION)
TABLE # 35 ROW COLLAGEN VASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)